Sign in

Research summary ·

Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This review looked at a stomach problem called gastroparesis. With it, the stomach empties too slowly. The team gathered reports of this problem in people on GLP-1 drugs. These drugs are used for type 2 diabetes and weight loss. They searched PubMed, Embase, Scopus and Web of Science up to October 2025. They summed up the signs, tests, care and outcomes in adults.

What they found

They found case reports on 13 patients in all. Most were women with type 2 diabetes, but some had no diabetes. Semaglutide was the drug named most often, then liraglutide, dulaglutide and exenatide. Signs began from hours to months after starting, often after a dose rise. People had nausea, vomiting, belly pain, bloating and quick fullness. Scans or scopes often showed a full stomach with no blockage. In every reported patient, signs went away once the drug was stopped.

What it means for patients

The authors say these drugs may cause or worsen gastroparesis. This may happen in people with or without diabetes. It was seen in particular after fast dose rises or wrong dosing. The authors say stopping the drug is central to care. In these reports, stopping was linked to good outcomes. It was also linked to the stomach working again. They say careful choice of patients and slow dose rises may help. Watching for gut signs that do not go away may also help.

Why it is not certain yet

The review held only case reports, on 13 patients. Each case report tells what happened to single people. Tests to confirm slow emptying were done only in some cases. A review can only be as good as the studies in it.

Source

Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes.

PubMed · PMID 42594084

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Gastroparesis publications